Post-COVID mRNA vaccine myocarditis in children: report of two cases

The SARS-COV-2 pandemic led to the development of several vaccinations to contain the disease. The Pfizer-BioNTech COVID-19 (BNT162b2) vaccine was recommended on May 2021 for use in children above 12 years and older. The vaccine is safe, well tolerated and highly effective. Initial reports showed no...

Descripción completa

Detalles Bibliográficos
Autores principales: Shamekh, Ahmed, Powell, Colin, Ashabani, Abdusamea, Abdelgadir, Ibtihal Siddiq
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Case Reports: Reminder of important clinical lesson
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710324/
https://www.ncbi.nlm.nih.gov/pubmed/36442910
http://dx.doi.org/10.1136/bcr-2022-253383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710324/
https://www.ncbi.nlm.nih.gov/pubmed/36442910
http://dx.doi.org/10.1136/bcr-2022-253383

Ejemplares similares